Additional Supporting Information may be found in the online version of this article.

lt23613-sup-0001-supptab1.doc147KSupporting Table 1. List of miRNA and associated P values for A-D analysis (Figure 2A main text, P<.01). * Multiple entries denote cross-species miRNA with sequence homology.
lt23613-sup-0002-supptab2.doc125KSupporting Table 2. List of miRNA and associated P values for A v B analysis (Supporting Figure 2A, P<.01)
lt23613-sup-0003-supptab3.doc150KSupporting Table 3. List of miRNA and associated P values for B v C analysis (Figure 5, P<.01). * Includes cross species miRNA
lt23613-sup-0004-suppfig1.tif2725KSupporting Figure 1: Consort diagram of patient selection. * HCV patients undergoing primary liver transplantation only ** Patients excluded; fibrosing cholestatic recurrence of HCV (n=10), undergoing re-liver transplantation (n=13), hepatocellular carcinoma (n=62), co-infection with HIV (n = 8), co-infection with HBV (n= 12), joint liver-kidney transplantation (n=1), survival less than 12 months (n=35), no 12 month liver biopsy available (n=25). *** Patients were matched according to recipient age, donor age, MELD score at transplant, viral genotype, donor-risk-index, cold-ischemia time, presence of diabetes, evidence of CMV viremia and immunosuppression regimen.
lt23613-sup-0005-suppfig2.tif579KSupporting Figure 2: miRNA expression distinguishes slow and fast progressors of HCV post transplant. (A) Hierarchical cluster analysis and cladogram for Groups A and B (P<.01). (B) Principal Component Analysis for the same data-set. miRNA list and associated P values shown in Supporting Table 2.
lt23613-sup-0006-suppinfo1.doc21KSupplementary Information
lt23613-sup-0007-suppinfo2.doc15KSupplementary Information

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.